Glurest FB

Composition : Glycopyrrolate IP 9 mcg + Formoterol Fumarate IP 6 mcg + Budesonide IP 160 mcg

Product Description

GLUREST-FB is a triple-combination inhalation formulation containing Glycopyrrolate 9 mcg, Formoterol Fumarate 4.8 mcg, and Budesonide 160 mcg. It combines a long-acting bronchodilator approach with an inhaled corticosteroid to support airway management and help improve breathing in patients with chronic obstructive respiratory conditions, as prescribed by a healthcare professional.

Indication

  • Maintenance treatment of chronic obstructive pulmonary disease (COPD)
  • Helps improve airflow and breathing
  • Supports long-term control of respiratory symptoms
  • Helps reduce airway inflammation and bronchoconstriction
  • For use as prescribed by a qualified healthcare professional

Key Benefits

  • Supports better airflow and easier breathing
  • Helps maintain long-lasting bronchodilation
  • Supports airway inflammation control
  • Helps improve respiratory function
  • Provides convenient combination inhalation therapy
Business Guide*
close slider
Scroll to Top

Download Product List